-+ 0.00%
-+ 0.00%
-+ 0.00%

Teradyne (TER) Could Be 45% Below Fair Value As Jefferies Starts With Buy

Simply Wall St·11/20/2026 09:08:43
Listen to the news

Jefferies has just initiated coverage on Teradyne (TER) with a Buy rating, spotlighting the business as a compute test specialist tied to AI demand, and highlighting recent revenue strength and newly profitable robotics operations.

Teradyne’s share price has pulled back sharply in the short term, with the 30 day share price return down 34.17% and the 90 day share price return down 39.47%. The stock still shows positive momentum over a longer horizon, with a 9.57% year to date share price return and a 1 year total shareholder return of 43.40%, alongside a 3 year total shareholder return of 148.27% and a 5 year total shareholder return of 58.29%. Jefferies’ fresh coverage and the recent Omnyx Edge product launch and dividend affirmation arrive as the market reassesses both growth potential and risk around the current US$227.43 price point.

Scan the AI hardware supply chain beyond Teradyne by reviewing the hand picked 53 AI infrastructure stocks that are also connected to the same compute and data center build out theme.

After a 30 day slide and a sharp 90 day reset, Teradyne now forces a choice. Investors can either lean into the current US$227.43 level, or hold out for an even cheaper entry as the valuation picture comes into focus next.

Most Popular Narrative: 45% Undervalued

Teradyne’s last close at $227.43 sits well below the fair value of $415.88 implied by the analyst consensus Narrative on Simply Wall St. That narrative ties the gap to specific AI test and robotics themes rather than simple multiple expansion.

The effort to become a dual-vendor tester at large compute and hyperscaler accounts has advanced, with correlation completed at a second major AI hyperscaler and the first merchant GPU order shipped in Q2 2026. This positions Teradyne to capture additional compute and AI accelerator test revenue and support EPS growth as share builds.

See why 127 investors see Teradyne as 45% undervalued.

Result: Fair Value of $415.88 (UNDERVALUED)

Still, the Teradyne narrative could unravel if AI related capital spending slows materially, or if higher R&D and go to market costs compress margins for longer than expected.

Find out about the key risks to this Teradyne narrative.

Next Steps

If the Teradyne story so far feels mixed, act while the details are fresh and test the thesis against the underlying numbers and context. To weigh both the concerns and the upside in one place, review the 5 key rewards and 2 important warning signs.

Looking for more ideas beyond Teradyne?

If Teradyne has sharpened your thinking, do not stop here. Broaden your watchlist now and give yourself more ways to put capital to work.